PC cell lines with knockout of METTL3 are highly sensitive to antitumour drugs such as gemcitabine, 5-fluorouracil, and cisplatin, as well as to radiotherapy, suggesting that METTL3 is an effective target for improving the efficacy of PC therapies [137]. This evidence concerns the gene METTL3 and pachyonychia congenita.